CTA
MRTX

Carillon Tower Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Carillon Tower Advisers’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		$34.1M Sell
155,365
-15,849
-9% -$3.48M 0.21% 150
2020
Q3 		$28.4M Sell
171,214
-28,600
-14% -$4.75M 0.38% 79
2020
Q2 		$22.8M Hold
199,814
– – 0.18% 173
2020
Q1 		$14.4M Hold
199,814
– – 0.14% 222
2019
Q4 		$25.7M Buy
+199,814
New +$25.7M 0.17% 206